J. Bertrand

发表

Determination of the MurD mechanism through crystallographic analysis of enzyme complexes.

E. Fanchon, O. Dideberg, D. Blanot, 1999, Journal of molecular biology.

Large-scale preparation, purification, and crystallization of UDP-N-acetylmuramoyl-L-alanine: D-glutamate ligase from Escherichia coli.

E. Fanchon, O. Dideberg, Y. Pétillot, 1998, Protein Expression and Purification.

Crystal structure of UDP‐N‐acetylmuramoyl‐L‐alanine:D‐glutamate ligase from Escherichia coli

E. Fanchon, O. Dideberg, D. Blanot, 1997, The EMBO journal.

Role of the ortholog and paralog amino acid invariants in the active site of the UDP-MurNAc-L-alanine:D-glutamate ligase (MurD).

O. Dideberg, D. Mengin-Lecreulx, D. Blanot, 1999, Biochemistry.

"Open" structures of MurD: domain movements and structural similarities with folylpolyglutamate synthetase.

E. Fanchon, O. Dideberg, D. Blanot, 2000, Journal of molecular biology.

Structural characterization of the GSK-3beta active site using selective and non-selective ATP-mimetic inhibitors.

S. Knapp, C. Cristiani, S. Thieffine, 2003, Journal of molecular biology.

Discovery of S-[5-amino-1-(4-fluorophenyl)-1H-pyrazol-4-yl]-[3-(2,3-dihydroxypropoxy)phenyl]methanone (RO3201195), an orally bioavailable and highly selective inhibitor of p38 MAP kinase.

D. Rotstein, C. Ramesha, M. Browner, 2006, Journal of medicinal chemistry.

Oxyanion-mediated inhibition of serine proteases.

C. Mura, L. Williams, K. Jude, 1998, Biochemistry.

Novel pyrrole carboxamide inhibitors of JAK2 as potential treatment of myeloproliferative disorders.

A. Isacchi, G. Canevari, E. Felder, 2015, Bioorganic & medicinal chemistry.

Tetramerization Dynamics of C-terminal Domain Underlies Isoform-specific cAMP Gating in Hyperpolarization-activated Cyclic Nucleotide-gated Channels*

M. Nardini, M. Bolognesi, M. Fasolini, 2011, The Journal of Biological Chemistry.

Synthetic deoxynojirimycin derivatives bearing a thiolated, fluorinated or unsaturated N-alkyl chain: identification of potent α-glucosidase and trehalase inhibitors as well as F508del-CFTR correctors.

J. Désiré, J. Bertrand, T. Legigan, 2015, Organic & biomolecular chemistry.

First Cdc7 kinase inhibitors: pyrrolopyridinones as potent and orally active antitumor agents. 2. Lead discovery.

A. Isacchi, A. Montagnoli, J. Berthelsen, 2009, Journal of medicinal chemistry.

Inhibition of trypsin and thrombin by amino(4-amidinophenyl)methanephosphonate diphenyl ester derivatives: X-ray structures and molecular models.

F. L. Suddath, L. Williams, J. Powers, 1996, Biochemistry.

Isocomene: a novel sesquiterpene from Isocoma Wrightii. X-Ray crystal structure of the corresponding diol

J. Bertrand, L. Zalkow, D. V. Derveer, 1977 .

The crystal and molecular structure of dibromobis(triphenylphosphine oxide)copper(II)

D. VanDerveer, S. Graham, J. Bertrand, 1971 .

Crystal and molecular structure of bis[N-(picolinoyl)-3-amino-1-propoxidoaquocopper(II)] dihydrate. A copper(II) dimer containing a bent four-membered ring

E. Fujita, J. Bertrand, P. Eller, 1974 .

Crystal and molecular structure of the radical perchloratotetraphenylporphinatozinc(II)

J. Bertrand, R. Felton, P. Eller, 1974 .

Crystal and molecular structure of bis{perchlorato[2-(2-hydroxyethyl)imino-3-oximobutanato]aquocopper(II)}. Copper(II) dimer with bridging oxime groups

J. Bertrand, P. Eller, John H. Smith, 1974 .

Polynuclear complexes with hydrogen-bonded bridges. 4. Structure and magnetic properties of dinuclear copper(II) complexes of amino alcohols

D. VanDerveer, E. Fujita, J. Bertrand, 1980 .

Polynuclear Complexes with Aminoalcohols and Iminoalcohols as Ligands: Oxygen-Bridged and Hydrogen-Bonded Species

J. Bertrand, P. Eller, 2007 .

CRYSTAL AND MOLECULAR STRUCTURE OF BIS(N‐(PICOLINOYL)‐3‐AMINO‐1‐PROPOXIDOAQUOCOPPER(II)) DIHYDRATE, A COPPER(II) DIMER CONTAINING A BENT FOUR‐MEMBERED RING

E. Fujita, J. Bertrand, P. Eller, 1974 .

Identification of 4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline derivatives as a new class of orally and selective Polo-like kinase 1 inhibitors.

D. Ballinari, V. Croci, D. Volpi, 2010, Journal of medicinal chemistry.

Polynuclear complexes with hydrogen-bonded bridges. 3. Oxygen-oxygen hydrogen bonding between tris chelates of 2-aminoethanol

D. VanDerveer, E. Fujita, M. Lively, 1979 .

CRYSTAL AND MOLECULAR STRUCTURE OF BIS(PERCHLORATO(2-(2-HYDROXYETHYL)IMINO-3-OXIMOBUTANATO)AQUOCOPPER(II)), A COPPER(II) DIMER WITH BRIDGING OXIME GROUPS

J. Bertrand, P. Eller, John H. Smith, 1974 .

Thieno[3,2-c]pyrazoles: a novel class of Aurora inhibitors with favorable antitumor activity.

V. Croci, D. Volpi, F. Roletto, 2010, Bioorganic & medicinal chemistry.

Alkylsulfanyl-1,2,4-triazoles, a new class of allosteric valosine containing protein inhibitors. Synthesis and structure-activity relationships.

A. Isacchi, E. Casale, T. O'Brien, 2013, Journal of medicinal chemistry.

POLYNUCLEAR COMPLEXES WITH HYDROGEN-BONDED BRIDGES. 4. STRUCTURE AND MAGNETIC C PROPERTIES OF DINUCLEAR COPPER(II) COMPLEXES OF AMINO ALCOHOLS

D. VanDerveer, E. Fujita, J. Bertrand, 1980 .

Structure of a tetranuclear cobalt(II)-cobalt(III) complex of bis(2-hydroxyethyl)amine, [Co4{NH(C2H4OH)2} 2{NH(C2H4O)2}4](ClO 4)2

D. VanDerveer, E. Fujita, J. Bertrand, 1979 .

Preparation, properties, and crystal structure of dichloro(1,3-dibenzoyl-2-azapropenato)(ethanol)iron(III)

D. VanDerveer, E. Fujita, J. Bertrand, 1978 .

Magnetic exchange in a copper(II) dimer with oxime bridging groups

J. Bertrand, P. Eller, John H. Smith, 1974 .

STRUCTURE OF TETRANUCLEAR COBALT(II)-COBALT(III) COMPLEX OF BIS(2-HYDROXYETHYL)AMINE, (CO4(NH(C2H4OH)2)2(NH(C2H4O)2)4)(CLO4)2

D. VanDerveer, E. Fujita, J. Bertrand, 1979 .

N- and C-alkylation of seven-membered iminosugars generates potent glucocerebrosidase inhibitors and F508del-CFTR correctors.

J. Marrot, D. Alonzi, T. Butters, 2014, Organic & biomolecular chemistry.

Water ring structure at DNA interfaces: hydration and dynamics of DNA-anthracycline complexes.

L. A. Lipscomb, D. VanDerveer, L. Williams, 1994, Biochemistry.

Spectra and structure of tris-bidentate cobalt(III) complexes containing planar ligands

J. Bertrand, P. Eller, D. J. Royer, 1978 .

Mechanism of Calcite Crystal Growth Inhibition by the N-terminal Undecapeptide of Lithostathine*

V. Gerbaud, D. Pignol, J. Fontecilla-Camps, 2000, The Journal of Biological Chemistry.

Crystal structure of human lithostathine, the pancreatic inhibitor of stone formation.

D. Pignol, J. Fontecilla-Camps, J. Dagorn, 1996, The EMBO journal.

Crystal structure of human lithostathine, the pancreatic inhibitor of stone formation.

D. Pignol, J. Fontecilla-Camps, J. Dagorn, 1996, EMBO Journal.

Crystallization and preliminary crystallographic study of human lithostathine

D. Pignol, J. Fontecilla-Camps, J. Dagorn, 1995, Proteins.

Structural basis for CARM1 inhibition by indole and pyrazole inhibitors.

K. Kish, H. Klei, D. Xie, 2011, The Biochemical journal.

Targeting the mitotic checkpoint for cancer therapy with NMS-P715, an inhibitor of MPS1 kinase.

Antonella Isacchi, Riccardo Colombo, Enrico Pesenti, 2010, Cancer research.

Structure of the substance C27H38O formed by the base-catalyzed self-condensation of isophorone

D. VanDerveer, J. Bertrand, H. O. House, 1977 .

Structural features associated with ?- anomerie in oligo-?-thymidylates

J. Bertrand, 1990 .

5-(2-amino-pyrimidin-4-yl)-1H-pyrrole and 2-(2-amino-pyrimidin-4-yl)-1,5,6,7-tetrahydro-pyrrolo[3,2-c]pyridin-4-one derivatives as new classes of selective and orally available Polo-like kinase 1 inhibitors.

D. Ballinari, F. Fiorentini, M. Brasca, 2012, Bioorganic & medicinal chemistry letters.

Crystal structures of anaplastic lymphoma kinase in complex with ATP competitive inhibitors.

Andrea Lombardi Borgia, Luisa Rusconi, Tiziano Bandiera, 2010, Biochemistry.

Mechanism of glycogen synthase inactivation and interaction with glycogenin

N. Ranson, C. Browning, C. Eyers, 2021, Nature Communications.

Structural insight into maternal embryonic leucine zipper kinase (MELK) conformation and inhibition toward structure-based drug design.

G. Canevari, E. Casale, E. Felder, 2013, Biochemistry.

The Crystal and Molecular Structure of Methyl Pinacol Phosphate

J. Bertrand, M. Newton, J. R. Cox, 1966 .

Identification of a phenylacylsulfonamide series of dual Bcl-2/Bcl-xL antagonists.

Andrew Tebben, Jonathan Lippy, Michele Modugno, 2012, Bioorganic & medicinal chemistry letters.

Structure of human Bloom's syndrome helicase in complex with ADP and duplex DNA.

P. Reaper, P. Charlton, Valérie Legris, 2014, Acta crystallographica. Section D, Biological crystallography.

Pyrrole-3-carboxamides as potent and selective JAK2 inhibitors.

A. Isacchi, G. Canevari, E. Felder, 2014, Bioorganic & medicinal chemistry.

CARBANIONS. 18. SPIRO ANIONS FROM REACTIONS OF 2- AND 3-P-BIPHENYLYLALKYL CHLORIDES WITH CESIUM-POTASSIUM-SODIUM ALLOY

D. VanDerveer, J. Bertrand, E. Grovenstein, 1976 .

Structure-Based Approaches to Improve Selectivity: CDK2-GSK3beta Binding Site Analysis

Patrizia Crivori, Anna Vulpetti, Alexander Cameron, 2005, J. Chem. Inf. Model..

The crystal structure of viomycidine

J. Dyer, J. Bertrand, J. C. Floyd, 1968 .

Targeting the mitotic checkpoint for cancer therapy with NMS-P715, an inhibitor of MPS1 kinase.

A. Isacchi, S. R. Depaolini, F. Colotta, 2010, Cancer Research.

Structural basis for CARM1 inhibition by indole and pyrazole inhibitors.

K. Kish, H. Klei, D. Xie, 2011, The Biochemical journal.

Pyrrole-3-carboxamides as potent and selective JAK2 inhibitors.

A. Isacchi, G. Canevari, E. Felder, 2014, Bioorganic & medicinal chemistry.

Sturcture-Based Approaches to Improve Selectivity: CDK2—GSK3β Binding Site Analysis.

A. Vulpetti, R. D'Alessio, P. Pevarello, 2005 .